Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Precision proton beam may boost transplant safety for tough blood cancers

NCT ID NCT07532824

First seen Apr 18, 2026 · Last updated May 25, 2026 · Updated 3 times

Summary

This study tests a new way to prepare people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) for a stem cell transplant. Instead of standard full-body radiation, participants receive targeted proton radiation to the bone marrow, combined with chemotherapy. The goal is to reduce side effects and improve survival. About 16 adults will take part, and they will be followed for at least two years after transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Hematology and Blood Transfusion

    RECRUITING

    Prague, 12800, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Proton Therapy Center Czech

    RECRUITING

    Prague, 18000, Czechia

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.